Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alain Bitton

Showing results (121-130 of 200) with videos related to

Pageof 20
Sort By:
Gastroenterology|January 28, 2014
Consensus statements on the risk, prevention, and treatment of venous thromboembolism in inflammatory bowel disease: Canadian Association of GastroenterologyGeoffrey C Nguyen, Charles N Bernstein, Alain Bitton, et al.
World Journal of Gastroenterology|September 26, 2022
Effectiveness, safety, and drug sustainability of biologics in elderly patients with inflammatory bowel disease: A retrospective studyGustavo Drügg Hahn, Jean-Frédéric LeBlanc, Petra Anna Golovics, et al.
Journal of the Canadian Association of Gastroenterology|July 12, 2019
The Impact of Inflammatory Bowel Disease in Canada 2018: Children and Adolescents with IBDMatthew W Carroll, M Ellen Kuenzig, David R Mack, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|November 7, 2017
Quality of care indicators in inflammatory bowel disease in a tertiary referral center with open access and objective assessment policiesLorant Gonczi, Zsuzsanna Kurti, Petra Anna Golovics, et al.
Journal of the Canadian Association of Gastroenterology|November 10, 2021
Crohn's and Colitis Canada's 2021 Impact of COVID-19 and Inflammatory Bowel Disease in Canada: Epidemiology-The Trends of Disease Over TimeStephanie Coward, Joseph W Windsor, M Ellen Kuenzig, et al.
Journal of the Canadian Association of Gastroenterology|November 10, 2021
Crohn's and Colitis Canada's 2021 Impact of COVID-19 and Inflammatory Bowel Disease in Canada: Mental Health and Quality of LifeLesley A Graff, Sharyle Fowler, Jennifer L Jones, et al.
Lancet (London, England)|September 7, 2015
Early combined immunosuppression for the management of Crohn's disease (REACT): a cluster randomised controlled trialReena Khanna, Brian Bressler, Barrett G Levesque, et al.
Journal of the Canadian Association of Gastroenterology|October 5, 2022
Efficacy of Intravenous Ustekinumab Reinduction in Patients With Crohn's Disease With a Loss of ResponseValerie Heron, Steven Li Fraine, Nicola Panaccione, et al.
Journal of the Canadian Association of Gastroenterology|November 10, 2021
Crohn's and Colitis Canada's 2021 Impact of COVID-19 and Inflammatory Bowel Disease in Canada: Seniors With IBDCharles N Bernstein, Harminder Singh, Sanjay K Murthy, et al.
Journal of the Canadian Association of Gastroenterology|November 10, 2021
Crohn's and Colitis Canada's 2021 Impact of COVID-19 and Inflammatory Bowel Disease in Canada: Health Care Delivery During the Pandemic and the Future Model of Inflammatory Bowel Disease CareJennifer L Jones, Eric I Benchimol, Charles N Bernstein, et al.
Pageof 20

Showing results (121-130 of 200) with videos related to

Sort By:
Pageof 20
Gastroenterology|January 28, 2014
Consensus statements on the risk, prevention, and treatment of venous thromboembolism in inflammatory bowel disease: Canadian Association of GastroenterologyGeoffrey C Nguyen, Charles N Bernstein, Alain Bitton, et al.
World Journal of Gastroenterology|September 26, 2022
Effectiveness, safety, and drug sustainability of biologics in elderly patients with inflammatory bowel disease: A retrospective studyGustavo Drügg Hahn, Jean-Frédéric LeBlanc, Petra Anna Golovics, et al.
Journal of the Canadian Association of Gastroenterology|July 12, 2019
The Impact of Inflammatory Bowel Disease in Canada 2018: Children and Adolescents with IBDMatthew W Carroll, M Ellen Kuenzig, David R Mack, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|November 7, 2017
Quality of care indicators in inflammatory bowel disease in a tertiary referral center with open access and objective assessment policiesLorant Gonczi, Zsuzsanna Kurti, Petra Anna Golovics, et al.
Journal of the Canadian Association of Gastroenterology|November 10, 2021
Crohn's and Colitis Canada's 2021 Impact of COVID-19 and Inflammatory Bowel Disease in Canada: Epidemiology-The Trends of Disease Over TimeStephanie Coward, Joseph W Windsor, M Ellen Kuenzig, et al.
Journal of the Canadian Association of Gastroenterology|November 10, 2021
Crohn's and Colitis Canada's 2021 Impact of COVID-19 and Inflammatory Bowel Disease in Canada: Mental Health and Quality of LifeLesley A Graff, Sharyle Fowler, Jennifer L Jones, et al.
Lancet (London, England)|September 7, 2015
Early combined immunosuppression for the management of Crohn's disease (REACT): a cluster randomised controlled trialReena Khanna, Brian Bressler, Barrett G Levesque, et al.
Journal of the Canadian Association of Gastroenterology|October 5, 2022
Efficacy of Intravenous Ustekinumab Reinduction in Patients With Crohn's Disease With a Loss of ResponseValerie Heron, Steven Li Fraine, Nicola Panaccione, et al.
Journal of the Canadian Association of Gastroenterology|November 10, 2021
Crohn's and Colitis Canada's 2021 Impact of COVID-19 and Inflammatory Bowel Disease in Canada: Seniors With IBDCharles N Bernstein, Harminder Singh, Sanjay K Murthy, et al.
Journal of the Canadian Association of Gastroenterology|November 10, 2021
Crohn's and Colitis Canada's 2021 Impact of COVID-19 and Inflammatory Bowel Disease in Canada: Health Care Delivery During the Pandemic and the Future Model of Inflammatory Bowel Disease CareJennifer L Jones, Eric I Benchimol, Charles N Bernstein, et al.
Pageof 20